Determinants of uptake of intermittent preventive treatment during pregnancy: a review

Malaria Journal

Kristin Andrejko¹  Katherine Wolf²  Elaine Roman²  Julie R. Gutman³  Erin Ferenchick⁴  Marianne Henry⁵  Susan Youll⁵  Lia Florey⁵ 

[1] Division of Epidemiology, School of Public Health, University of California, Berkeley;Jhpiego;Malaria Branch, Division of Parasitic Diseases and Malaria, U.S Centers for Disease Control and Prevention;The Global Fund to Fight AIDS, Tuberculosis and Malaria;U.S. President’s Malaria Initiative, U.S. Agency for International Development;

关键词: Malaria;    Pregnancy;    Intermittent preventive treatment;    Sulfadoxine–pyrimethamine;   

DOI  :  10.1186/s12936-019-3004-7

来源: DOAJ

【 摘 要 】

Abstract Malaria in pregnancy (MiP) contributes to devastating maternal and neonatal outcomes. Coverage of intermittent preventive treatment during pregnancy (IPTp) remains alarmingly low. Data was compiled from MiP programme reviews and performed a literature search on access to and determinants of IPTp. National malaria control and reproductive health (RH) policies may be discordant. Integration may improve coverage. Medication stock-outs are a persistent problem. Quality improvement programmes are often not standardized. Capacity building varies across countries. Community engagement efforts primarily focus on promotion of services. The majority of challenges can be addressed at country level to improve IPTp coverage.

【 授权许可】

Unknown